NCT05150691 2026-01-28
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
DualityBio Inc.
Phase 1/2 Recruiting
DualityBio Inc.
Massachusetts General Hospital
Cancer Research UK
IFOM ETS - The AIRC Institute of Molecular Oncology
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)